Loading…
No Tax Subsidies for E-Cigarette and Tobacco Ads Act
Legislative Progress
Introduced
February 16, 2023
Latest Action
February 16, 2023
Primary Sponsor
Jeanne ShaheenDemocratic(NH)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,649 other S bills in the 118th — cohort avg 33d
No Tax Subsidies for E-Cigarette and Tobacco Ads Act This bill denies a tax deduction for expenses relating to direct-to-consumer advertising of tobacco products, including electronic nicotine delivery systems.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (12)
Read twice and referred to the Committee on Finance.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2026 · third_quarter · Taxation/Internal Revenue Code
S. 464, No Tax Subsidies for E-Cigarette and Tobacco Ads Act; S. 2929/H.R. 5715, Tobacco Tax Equity Act; Issues surrounding Internal Revenue Code 420; Discussions concerning the tax rate on corporate stock buybacks and U.S. multinationals foreign earnings; Discussions concerning draft legislation to amend corporate tax rates and federal excise taxes/duties on tobacco products; Discussions concerning a retaliatory tax on international companies from countries that adopt extraterritorial tax schemes; Issues surrounding taxation of tobacco products.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Taxation/Internal Revenue Code
S. 464, No Tax Subsidies for E-Cigarette and Tobacco Ads Act S. 2929/H.R. 5715, Tobacco Tax Equity Act Issues surrounding Internal Revenue Code 420 Discussions concerning the tax rate on corporate stock buybacks and U.S. multinationals foreign earnings Discussions concerning draft legislation to amend corporate tax rates and federal excise taxes/duties on tobacco products Discussions concerning a retaliatory tax on international companies from countries that adopt extraterritorial tax schemes Issues surrounding taxation of tobacco products
Client expense: $2,000,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Taxation/Internal Revenue Code
S. 464, No Tax Subsidies for E-Cigarette and Tobacco Ads Act; S. 2929/H.R. 5715, Tobacco Tax Equity Act; Issues surrounding Internal Revenue Code 420; Discussions concerning the tax rate on corporate stock buybacks and U.S. multinationals foreign earnings; Discussions concerning draft legislation to amend corporate tax rates and federal excise taxes/duties on tobacco products; Discussions concerning a retaliatory tax on international companies from countries that adopt extraterritorial tax schemes; Issues surrounding taxation of tobacco products.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Taxation/Internal Revenue Code
S. 464, No Tax Subsidies for E-Cigarette and Tobacco Ads Act S. 2929/H.R. 5715, Tobacco Tax Equity Act Issues surrounding Internal Revenue Code 420 Discussions concerning the tax rate on corporate stock buybacks and U.S. multinationals foreign earnings Discussions concerning draft legislation to amend corporate tax rates and federal excise taxes/duties on tobacco products Discussions concerning a retaliatory tax on international companies from countries that adopt extraterritorial tax schemes Issues surrounding taxation of tobacco products
Client expense: $1,990,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Taxation/Internal Revenue Code
S. 464, No Tax Subsidies for E-Cigarette and Tobacco Ads Act; S. 2929/H.R. 5715, Tobacco Tax Equity Act; Issues surrounding Internal Revenue Code 420; Discussions concerning the tax rate on corporate stock buybacks and U.S. multinationals foreign earnings; Discussions concerning draft legislation to amend corporate tax rates and federal excise taxes/duties on tobacco products; Discussions concerning a retaliatory tax on international companies from countries that adopt extraterritorial tax schemes; Issues surrounding taxation of tobacco products.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
| Democratic |
| IL |
| Sherrod Brown | Democratic | OH |
2026 · first_quarter · Taxation/Internal Revenue Code
S. 464, No Tax Subsidies for E-Cigarette and Tobacco Ads Act S. 2929/H.R. 5715, Tobacco Tax Equity Act Issues surrounding Internal Revenue Code 420 Discussions concerning the tax rate on corporate stock buybacks and U.S. multinationals foreign earnings Discussions concerning draft legislation to amend corporate tax rates and federal excise taxes/duties on tobacco products Discussions concerning a retaliatory tax on international companies from countries that adopt extraterritorial tax schemes Issues surrounding taxation of tobacco products
Client expense: $1,850,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · fourth_quarter · Taxation/Internal Revenue Code
S. 464, No Tax Subsidies for E-Cigarette and Tobacco Ads Act S. 2929/H.R. 5715, Tobacco Tax Equity Act Issues surrounding Internal Revenue Code 420 Discussions concerning the tax rate on corporate stock buybacks and U.S. multinationals foreign earnings Discussions concerning draft legislation to amend corporate tax rates and federal excise taxes/duties on tobacco products Discussions concerning a retaliatory tax on international companies from countries that adopt extraterritorial tax schemes Issues surrounding taxation of tobacco products
Client expense: $1,860,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · fourth_quarter · Taxation/Internal Revenue Code
S. 464, No Tax Subsidies for E-Cigarette and Tobacco Ads Act; S. 2929/H.R. 5715, Tobacco Tax Equity Act; Issues surrounding Internal Revenue Code 420; Discussions concerning the tax rate on corporate stock buybacks and U.S. multinationals foreign earnings; Discussions concerning draft legislation to amend corporate tax rates and federal excise taxes/duties on tobacco products; Discussions concerning a retaliatory tax on international companies from countries that adopt extraterritorial tax schemes; Issues surrounding taxation of tobacco products.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · third_quarter · Taxation/Internal Revenue Code
S. 464, No Tax Subsidies for E-Cigarette and Tobacco Ads Act S. 2929/H.R. 5715, Tobacco Tax Equity Act Issues surrounding Internal Revenue Code 420 Discussions concerning the tax rate on corporate stock buybacks and U.S. multinationals foreign earnings Discussions concerning draft legislation to amend corporate tax rates and federal excise taxes/duties on tobacco products Discussions concerning a retaliatory tax on international companies from countries that adopt extraterritorial tax schemes. Issues surrounding taxation of tobacco products
Client expense: $1,650,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · third_quarter · Taxation/Internal Revenue Code
S. 464, No Tax Subsidies for E-Cigarette and Tobacco Ads Act; S. 2929/H.R. 5715, Tobacco Tax Equity Act; Issues surrounding Internal Revenue Code 420; Discussions concerning the tax rate on corporate stock buybacks and U.S. multinationals foreign earnings; Discussions concerning draft legislation to amend corporate tax rates and federal excise taxes/duties on tobacco products; Discussions concerning a retaliatory tax on international companies from countries that adopt extraterritorial tax schemes; Issues surrounding taxation of tobacco products.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · second_quarter · Taxation/Internal Revenue Code
S. 464, No Tax Subsidies for E-Cigarette and Tobacco Ads Act S. 2929/H.R. 5715, Tobacco Tax Equity Act Issues surrounding Internal Revenue Code 420 Discussions concerning the tax rate on corporate stock buybacks and U.S. multinationals foreign earnings Discussions concerning draft legislation to amend corporate tax rates and federal excise taxes/duties on tobacco products Discussions concerning a retaliatory tax on international companies from countries that adopt extraterritorial tax schemes. Issues surrounding taxation of tobacco products
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · second_quarter · Taxation/Internal Revenue Code
S. 464, No Tax Subsidies for E-Cigarette and Tobacco Ads Act S. 2929/H.R. 5715, Tobacco Tax Equity Act Issues surrounding Internal Revenue Code 420 Discussions concerning the tax rate on corporate stock buybacks and U.S. multinationals foreign earnings Discussions concerning draft legislation to amend corporate tax rates and federal excise taxes/duties on tobacco products Discussions concerning a retaliatory tax on international companies from countries that adopt extraterritorial tax schemes. Issues surrounding taxation of tobacco products
Client expense: $1,850,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · first_quarter · Taxation/Internal Revenue Code
S. 464, No Tax Subsidies for E-Cigarette and Tobacco Ads Act S. 2929/H.R. 5715, Tobacco Tax Equity Act Issues surrounding Internal Revenue Code 420 Discussions concerning the tax rate on corporate stock buybacks and U.S. multinationals foreign earnings Discussions concerning draft legislation to amend corporate tax rates and federal excise taxes/duties on tobacco products Discussions concerning a retaliatory tax on international companies from countries that adopt extraterritorial tax schemes. Issues surrounding taxation of tobacco products
Client expense: $1,900,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Tobacco
HR 901 Disposable ENDS Product Enforcement Act of 2023; all provisions of the bill HJRes 99 To amend the Federal Food Drug and Cosmetic Act to exempt the premium cigar industry from certain regulations; all provisions of the bill H. Res. 979 Expressing the sense of the House of Representatives that public health authorities and tobacco control advocates should encourage American innovation and embrace harm reduction as part of the comprehensive United States approach to tobacco control HR 1486 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2023; all provisions of the bill HR 8070/ S 4638 Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025; Section 1704, provisions related to enforcement efforts regarding illicit e-cigarettes and other unauthorized tobacco products HR 9425 Tobacco User Fee Modernization Act of 2024; all provisions of the bill S 464 No Tax Subsidies for E-Cigarette and Tobacco Ads Act; all provisions of the bill ANPRM for Docket No. FDA-2017-N-6189 Implementation of P.L. 111-31 Family Smoking Prevention and Tobacco Control Act Implementation of P.L. 117-103 Consolidated Appropriations Act, 2022; provisions related to providing FDA authority to regulate products containing synthetic nicotine Discussions related to tobacco harm reduction Discussions concerning proposals to ban characterizing flavors in tobacco products FDA-2021-N-1309, Proposed Rule regarding Tobacco Product Standard for Characterizing Flavors in Cigars FDA-2021-N-1349, Proposed Rule regarding Tobacco Product Standard for Menthol in Cigarettes Discussions regarding the FDAs need to urgently implement a compliance and enforcement plan to address and prohibit the importation and sale of illicit flavored, disposable electronic nicotine delivery system (ENDS) products Discussions concerning nicotine analogue products and FDAs regulatory authority over such products
Client expense: $3,770,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Tobacco
Issues related to lung disease treatment, prevention and research; Issues related to tobacco cessation; Issues related to smokefree air; Issues related to the Tobacco Control Act; Issues related to tobacco smuggling; Issues related to the Affordable Care Act; Issues related to menthol cigarettes; Issues related to tobacco prevention; Issues related to youth cessation research; Issues related to nicotine; Issues related to health equity; Issues related to COVID-19 Response; Issues related to tobacco litter; Issues related to synthetic nicotine; Issues related to regulatory reform;; Issues relating to FY25 appropriations; Issues relating to the Presidents FY26 budget; HR 277 REINS Act; S 184 REINS Act; S. 107 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2023; HR 901 To require the Food and Drug Administration to prioritize enforcement of disposable electronic nicotine delivery system products; S. 464 No Tax Subsidies for E-Cigarette and Tobacco Ads; HR 2811 Limit Save Grow Act; HR 442 Regulatory Accountability Act; S 1615 Regulatory Accountability Act;; HR 288 Separation of Powers Restoration Act of 2023;; HR 4020 Children Don't Belong on Tobacco Farms Act;; S 1411, Prove It Act of 2023; HR 4286 Increasing Access to Lung Cancer Screening Act; S 2213 Comprehensive Cancer Survivorship Act; HR 4363 Comprehensive Cancer Survivorship Act; HR 2398 To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes.; S 1040 To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes; ; HR 890 The Guidance Out of Darkness Act; S 791 The Guidance Out of Darkness Act; HR 4775 Helping Tobacco Users Quit Act; S 3108 Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act; HR 6038 Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act; HR 357 Ensuring Accountability in Agency Rulemaking; SJ Res 99 Exclude premium cigars from FDA oversight; issues related to enforcement of illegal vaping; HR 7867 Renewing Efficiency in Government by Budgeting Act; HR 115 Midnight Rules Relief Act; HR 9027 Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2025; HR 9029 Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations Act, 2025; HR 9367 Preventing Vape Use Act; S. 4942 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025; S 4690 Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2025; HR 890 Guidance out of Regulatory Darkness Act; HR 10515, American Relief Act, 2025; HR 10545, American Relief Act, 2025
Client expense: $60,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
2024 · fourth_quarter · Taxation/Internal Revenue Code
Issues related to taxes on tobacco products; Issues related to the Affordable Care Act; Issues related to COVID-19; Issues related to infrastructure; Issues relating to the Presidents FY25 budget; Issues relating to the Presidents FY26 budget; S. 464 No Tax Subsidies for E-Cigarette and Tobacco Ads; SJ Res 87 A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of the Treasury relating to "Clean Vehicle Credits Under Sections 25E and 30D; Transfer of Credits; Critical Minerals and Battery Components; Foreign Entities of Concern; HJ Res 148 A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of the Treasury relating to "Clean Vehicle Credits Under Sections 25E and 30D; Transfer of Credits; Critical Minerals and Battery Components; Foreign Entities of Concern
Client expense: $60,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), SENATE, White House Office
2024 · fourth_quarter · Taxation/Internal Revenue Code
S. 464, No Tax Subsidies for E-Cigarette and Tobacco Ads Act S. 2929/H.R. 5715, Tobacco Tax Equity Act Issues surrounding Internal Revenue Code 420 Discussions concerning the tax rate on corporate stock buybacks and U.S. multinationals foreign earnings Discussions concerning draft legislation to amend corporate tax rates and federal excise taxes on tobacco products Discussions concerning a retaliatory tax on international companies from countries that adopt extraterritorial tax schemes Issues surrounding taxation of tobacco products
Client expense: $1,610,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Taxation/Internal Revenue Code
S.464 No Tax Subsidies for E-Cigarette and Tobacco Ads Act H.R.5715/S.2929 Tobacco Tax Equity Act of 2023 Tobacco tax provisions in H.R.5568/S.2846 Care for Mom's Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Taxation/Internal Revenue Code
S.464 No Tax Subsidies for E-Cigarette and Tobacco Ads Act H.R.5715/S.2929 Tobacco Tax Equity Act of 2023 Tobacco tax provisions in H.R.5568/S.2846 Care for Mom's Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Tobacco
HR 901 Disposable ENDS Product Enforcement Act of 2023; all provisions of the bill HJRes 99 To amend the Federal Food Drug and Cosmetic Act to exempt the premium cigar industry from certain regulations; all provisions of the bill H. Res. 979 Expressing the sense of the House of Representatives that public health authorities and tobacco control advocates should encourage American innovation and embrace harm reduction as part of the comprehensive United States approach to tobacco control HR 1486 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2023; all provisions of the bill HR 8070/ S 4638 Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025; Section 1704, provisions related to enforcement efforts regarding illicit e-cigarettes and other unauthorized tobacco products HR 9425 Tobacco User Fee Modernization Act of 2024; all provisions of the bill S 464 No Tax Subsidies for E-Cigarette and Tobacco Ads Act; all provisions of the bill ANPRM for Docket No. FDA-2017-N-6189 Implementation of P.L. 111-31 Family Smoking Prevention and Tobacco Control Act Implementation of P.L. 117-103 Consolidated Appropriations Act, 2022; provisions related to providing FDA authority to regulate products containing synthetic nicotine Discussions related to tobacco harm reduction Discussions concerning proposals to ban characterizing flavors in tobacco products FDA-2021-N-1309, Proposed Rule regarding Tobacco Product Standard for Characterizing Flavors in Cigars FDA-2021-N-1349, Proposed Rule regarding Tobacco Product Standard for Menthol in Cigarettes Discussions regarding the FDAs need to urgently implement a compliance and enforcement plan to address and prohibit the importation and sale of illicit flavored, disposable electronic nicotine delivery system (ENDS) products Discussions concerning nicotine analogue products and FDAs regulatory authority over such products
Client expense: $3,130,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2024 · third_quarter · Taxation/Internal Revenue Code
S. 464, No Tax Subsidies for E-Cigarette and Tobacco Ads Act S. 2929/H.R. 5715, Tobacco Tax Equity Act Issues surrounding Internal Revenue Code 420 Discussions concerning the tax rate on corporate stock buybacks and U.S. multinationals foreign earnings Discussions concerning draft legislation to amend corporate tax rates and federal excise taxes on tobacco products Discussions concerning a retaliatory tax on international companies from countries that adopt extraterritorial tax schemes Issues surrounding taxation of tobacco products
Client expense: $1,440,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Tobacco
Issues related to lung disease treatment, prevention and research; Issues related to tobacco cessation; Issues related to smokefree air; Issues related to the Tobacco Control Act; Issues related to tobacco smuggling; Issues related to the Affordable Care Act; Issues related to menthol cigarettes; Issues related to tobacco prevention; Issues related to youth cessation research; Issues related to nicotine; Issues related to health equity; Issues related to COVID-19 Response; Issues related to tobacco litter; Issues related to synthetic nicotine; Issues related to regulatory reform;; Issues relating to FY25 appropriations; Issues relating to the Presidents FY26 budget; HR 277 REINS Act; S 184 REINS Act; S. 107 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2023; HR 901 To require the Food and Drug Administration to prioritize enforcement of disposable electronic nicotine delivery system products; S. 464 No Tax Subsidies for E-Cigarette and Tobacco Ads; HR 2811 Limit Save Grow Act; HR 442 Regulatory Accountability Act; S 1615 Regulatory Accountability Act;; HR 288 Separation of Powers Restoration Act of 2023;; HR 4020 Children Don't Belong on Tobacco Farms Act;; S 1411, Prove It Act of 2023; HR 4286 Increasing Access to Lung Cancer Screening Act; S 2213 Comprehensive Cancer Survivorship Act; HR 4363 Comprehensive Cancer Survivorship Act; HR 2398 To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes.; S 1040 To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes; ; HR 890 The Guidance Out of Darkness Act; S 791 The Guidance Out of Darkness Act; HR 4775 Helping Tobacco Users Quit Act; S 3108 Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act; HR 6038 Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act; HR 357 Ensuring Accountability in Agency Rulemaking; SJ Res 99 Exclude premium cigars from FDA oversight; issues related to enforcement of illegal vaping; HR 7867 Renewing Efficiency in Government by Budgeting Act; HR 115 Midnight Rules Relief Act; HR 9027 Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2025; HR 9029 Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations Act, 2025; HR 9367 Preventing Vape Use Act; S. 4942 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025; S 4690 Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2025; HR 890 Guidance out of Regulatory Darkness Act; HR 9747 Continuing Appropriations and Extensions Act, 2025; HR 9494 Continuing Appropriations and Other Matters Act 2025
Client expense: $180,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
2024 · third_quarter · Taxation/Internal Revenue Code
Issues related to taxes on tobacco products; Issues related to the Affordable Care Act; Issues related to COVID-19; Issues related to infrastructure; Issues relating to the Presidents FY25 budget; Issues relating to the Presidents FY26 budget; S. 464 No Tax Subsidies for E-Cigarette and Tobacco Ads; SJ Res 87 A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of the Treasury relating to "Clean Vehicle Credits Under Sections 25E and 30D; Transfer of Credits; Critical Minerals and Battery Components; Foreign Entities of Concern; HJ Res 148 A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of the Treasury relating to "Clean Vehicle Credits Under Sections 25E and 30D; Transfer of Credits; Critical Minerals and Battery Components; Foreign Entities of Concern
Client expense: $180,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2024 · second_quarter · Taxation/Internal Revenue Code
S.464 No Tax Subsidies for E-Cigarette and Tobacco Ads Act H.R.5715/S.2929 Tobacco Tax Equity Act of 2023 Tobacco tax provisions in H.R.5568/S.2846 Care for Mom's Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Taxation/Internal Revenue Code
Issues related to taxes on tobacco products; Issues related to the Affordable Care Act; Issues related to COVID-19; Issues related to infrastructure; Issues relating to the Presidents FY25 budget; Issues relating to the Presidents FY26 budget; S. 464 No Tax Subsidies for E-Cigarette and Tobacco Ads; SJ Res 87 A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of the Treasury relating to "Clean Vehicle Credits Under Sections 25E and 30D; Transfer of Credits; Critical Minerals and Battery Components; Foreign Entities of Concern; HJ Res 148 A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of the Treasury relating to "Clean Vehicle Credits Under Sections 25E and 30D; Transfer of Credits; Critical Minerals and Battery Components; Foreign Entities of Concern
Client expense: $60,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2024 · second_quarter · Tobacco
Issues related to lung disease treatment, prevention and research; Issues related to tobacco cessation; Issues related to smokefree air; Issues related to the Tobacco Control Act; Issues related to tobacco smuggling; Issues related to the Affordable Care Act; Issues related to menthol cigarettes; Issues related to tobacco prevention; Issues related to youth cessation research; Issues related to nicotine; Issues related to health equity; Issues related to COVID-19 Response; Issues related to tobacco litter; Issues related to synthetic nicotine; Issues related to regulatory reform;; Issues relating to FY25 appropriations; Issues relating to the Presidents FY26 budget; HR 277 REINS Act; S 184 REINS Act; S. 107 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2023; HR 901 To require the Food and Drug Administration to prioritize enforcement of disposable electronic nicotine delivery system products; S. 464 No Tax Subsidies for E-Cigarette and Tobacco Ads; HR 2811 Limit Save Grow Act; HR 442 Regulatory Accountability Act; S 1615 Regulatory Accountability Act;; HR 288 Separation of Powers Restoration Act of 2023;; HR 4020 Children Don't Belong on Tobacco Farms Act;; S 1411, Prove It Act of 2023; HR 4286 Increasing Access to Lung Cancer Screening Act; S 2213 Comprehensive Cancer Survivorship Act; HR 4363 Comprehensive Cancer Survivorship Act; HR 2398 To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes.; S 1040 To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes; ; HR 890 The Guidance Out of Darkness Act; S 791 The Guidance Out of Darkness Act; HR 4775 Helping Tobacco Users Quit Act; S 3108 Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act; HR 6038 Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act; HR 357 Ensuring Accountability in Agency Rulemaking; SJ Res 99 Exclude premium cigars from FDA oversight; issues related to enforcement of illegal vaping; HR 7867 Renewing Efficiency in Government by Budgeting Act; HR 115 Midnight Rules Relief Act; Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2025; Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations Act, 2025;
Client expense: $60,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
2024 · second_quarter · Taxation/Internal Revenue Code
S. 464, No Tax Subsidies for E-Cigarette and Tobacco Ads Act S. 2929/H.R. 5715, Tobacco Tax Equity Act Issues surrounding Internal Revenue Code 420 Discussions concerning the tax rate on corporate stock buybacks and U.S. multinationals foreign earnings Discussions concerning draft legislation to amend corporate tax rates and federal excise taxes on tobacco products Discussions concerning a retaliatory tax on international companies from countries that adopt extraterritorial tax schemes Issues surrounding taxation of tobacco products
Client expense: $1,390,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Tobacco
Issues related to lung disease treatment, prevention and research; Issues related to tobacco cessation; Issues related to smokefree air; Issues related to the Tobacco Control Act; Issues related to tobacco smuggling; Issues related to the Affordable Care Act; Issues related to menthol cigarettes; Issues related to tobacco prevention; Issues related to youth cessation research; Issues related to nicotine; Issues related to health equity; Issues related to COVID-19 Response; Issues related to tobacco litter; Issues related to synthetic nicotine; Issues related to regulatory reform; Issues relating to the Presidents FY24 budget; Issues relating to FY25 appropriations; HR 277 REINS Act; S 184 REINS Act; S. 107 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2023; HR 901 To require the Food and Drug Administration to prioritize enforcement of disposable electronic nicotine delivery system products; S. 464 No Tax Subsidies for E-Cigarette and Tobacco Ads; HR 2811 Limit Save Grow Act; HR 442 Regulatory Accountability Act; S 1615 Regulatory Accountability Act;; HR 288 Separation of Powers Restoration Act of 2023; HR 4368 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024; S.2131 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024; HR 4020 Children Don't Belong on Tobacco Farms Act; Issues related to Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2024; S 1411, Prove It Act of 2023; HR 4286 Increasing Access to Lung Cancer Screening Act; S 2213 Comprehensive Cancer Survivorship Act; HR 4363 Comprehensive Cancer Survivorship Act; HR 2398 To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes.; S 1040 To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes; S 2624 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024; ; HR 890 The Guidance Out of Darkness Act; S 791 The Guidance Out of Darkness Act; HR 4775 Helping Tobacco Users Quit Act; HR 5894 Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2024, and for other purposes; S 3108 Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act; HR 6038 Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act; HR 357 Ensuring Accountability in Agency Rulemaking; SJ Res 99 Exclude premium cigars from FDA oversight; ; HR 7463 Extension of Continuing Appropriations and Other Matters Act, 2024; HR 2872 Further Additional Continuing Appropriations and Other Extensions Act, 2024; HR4366 Consolidated Appropriations Act, 2024; HR 2882 Further Consolidated Appropriations Act, 2024; issues related to enforcement of illegal vaping;
Client expense: $220,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
2024 · first_quarter · Taxation/Internal Revenue Code
Issues related to taxes on tobacco products; Issues related to the Affordable Care Act; Issues related to COVID-19; Issues related to infrastructure; Issues relating to the Presidents FY25 budget; S. 464 No Tax Subsidies for E-Cigarette and Tobacco Ads.
Client expense: $220,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2024 · first_quarter · Taxation/Internal Revenue Code
S. 464, No Tax Subsidies for E-Cigarette and Tobacco Ads Act S. 2929/H.R. 5715, Tobacco Tax Equity Act Issues surrounding Internal Revenue Code 420 Discussions concerning the tax rate on corporate stock buybacks and U.S. multinationals foreign earnings Discussions concerning draft legislation to amend corporate tax rates and federal excise taxes on tobacco products Discussions concerning a retaliatory tax on international companies from countries that adopt extraterritorial tax schemes Issues surrounding taxation of tobacco products
Client expense: $1,220,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Taxation/Internal Revenue Code
Discussions involving federal excise tax. Monitored S.464, No Subsidies for E-Cigarette and Tobacco Ads Act Monitored S.2929, Tobacco Tax Equity Act of 2023 Monitored H.R.5715, Tobacco Tax Equity Act of 2023
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Taxation/Internal Revenue Code
S.464 No Tax Subsidies for E-Cigarette and Tobacco Ads Act H.R.5715/S.2929 Tobacco Tax Equity Act of 2023 Tobacco tax provisions in H.R.5568/S.2846 Care for Mom's Act
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · fourth_quarter · Taxation/Internal Revenue Code
S.464 No Tax Subsidies for E-Cigarette and Tobacco Ads Act H.R.5715/S.2929 Tobacco Tax Equity Act of 2023 Tobacco tax provisions in H.R.5568/S.2846 Care for Mom's Act
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · fourth_quarter · Taxation/Internal Revenue Code
Issues related to taxes on tobacco products; Issues related to the Affordable Care Act; Issues related to COVID-19; Issues related to infrastructure; Issues relating to the Presidents FY24 budget; S. 464 No Tax Subsidies for E-Cigarette and Tobacco Ads.
Client expense: $60,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2023 · fourth_quarter · Tobacco
Issues related to lung disease treatment, prevention and research; Issues related to tobacco cessation; Issues related to smokefree air; Issues related to the Tobacco Control Act; Issues related to tobacco smuggling; Issues related to the Affordable Care Act; Issues related to menthol cigarettes; Issues related to tobacco prevention; Issues related to youth cessation research; Issues related to nicotine; Issues related to health equity; Issues related to COVID-19 Response; Issues related to tobacco litter; Issues related to synthetic nicotine; Issues related to regulatory reform; Issues relating to the Presidents FY24 budget; Issues relating to FY24 appropriations; HR 277 REINS Act; S 184 REINS Act; S. 107 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2023; HR 901 To require the Food and Drug Administration to prioritize enforcement of disposable electronic nicotine delivery system products; S. 464 No Tax Subsidies for E-Cigarette and Tobacco Ads; HR 2811 Limit Save Grow Act; HR 442 Regulatory Accountability Act; S 1615 Regulatory Accountability Act;; HR 288 Separation of Powers Restoration Act of 2023; HR 4368 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024; S.2131 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024; HR 4020 Children Don't Belong on Tobacco Farms Act; Issues related to Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2024; S 1411, Prove It Act of 2023; HR 4286 Increasing Access to Lung Cancer Screening Act; S 2213 Comprehensive Cancer Survivorship Act; HR 4363 Comprehensive Cancer Survivorship Act; HR 2398 To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes.; S 1040 To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes; S 2624 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024; HR 4286 Increasing Access to Lung Cancer Screening Act; HR 890 The Guidance Out of Darkness Act; S 791 The Guidance Out of Darkness Act; HR 4775 Helping Tobacco Users Quit Act; HR 5894 Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2024, and for other purposes; S 3108 Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act; HR 6038 Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act; HR 357 Ensuring Accountability in Agency Rulemaking; SJ Res 99 Exclude premium cigars from FDA oversight; HR 6363 Further Continuing Appropriations and Other Extensions Act, 2024
Client expense: $60,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
2023 · fourth_quarter · Taxation/Internal Revenue Code
Discussions involving federal excise tax. Monitored S.464, No Subsidies for E-Cigarette and Tobacco Ads Act Monitored S.2929, Tobacco Tax Equity Act of 2023 Monitored H.R.5715, Tobacco Tax Equity Act of 2023
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · fourth_quarter · Taxation/Internal Revenue Code
S. 464, No Tax Subsidies for E-Cigarette and Tobacco Ads Act S. 2929/H.R. 5715, Tobacco Tax Equity Act Issues surrounding Internal Revenue Code 420 Discussions concerning the tax rate on corporate stock buybacks and U.S. multinationals foreign earnings Discussions concerning draft legislation to amend corporate tax rates and federal excise taxes on tobacco products Discussions concerning a retaliatory tax on international companies from countries that adopt extraterritorial tax schemes Issues surrounding taxation of tobacco products
Client expense: $860,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · fourth_quarter · Health Issues
Palliative Care and Hospice Education and Training Act (PCHETA) (S.2243), Cancer Drug Parity Act (S.2039/H.R. 6301), Improving Care and Access to Nurses (H.R.2713/S. 2418), No Tax Subsidies for E-Cigarette and Tobacco Ads Act (S. 464/H.R. 4368), Safe Step Act (S. 652/H.R. 2630), National Triple-Negative Breast Cancer Day Resolution (H.R. 172), National Colorectal Cancer Awareness Month Resolution (H.R.213),Barbosa Act (S.302), Reducing Hereditary Cancer Act (S.765/H.R. 1526), National Cancer Prevention Day Resolution (H.R. 93), Colorectal Cancer Disparities Resolution (H.Res.224) Improving Senior's Timely Access to Care Act (H.R. 4822),
Client expense: $73,657 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, White House Office
2023 · third_quarter · Taxation/Internal Revenue Code
S.464 No Tax Subsidies for E-Cigarette and Tobacco Ads Act H.R.5715/S.2929 Tobacco Tax Equity Act of 2023 Tobacco tax provisions in H.R.5568/S.2846 Care for Mom's Act
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · third_quarter · Health Issues
Issues related to surprise billing law and regulation. Issues related to P.L. 117-328, the Consolidated Appropriations Act 2023, including telehealth and redeterminations. Issues related to P.L. 117-169, the Inflation Reduction Act of 2022, including enhanced advance premium tax credits (APTCs) and Medicare Part D redesign. Issues related to removing barriers to biosimilar medicine access. Issues related to the proposed rule on Advancing Interoperability and Improving Prior Authorization Processes for Medicare Advantage Organizations, Medicaid Managed Care Plans, State Medicaid Agencies, Childrens Health Insurance Program (CHIP) Agencies and CHIP Managed Care Entities, Issuers of Qualified Health Plans on the Federally-facilitated Exchanges, Merit-based Incentive Payment System (MIPS) Eligible Clinicians, and Eligible Hospitals and Critical Access Hospitals in the Medicare Promoting Interoperability Program. Issues related to insulin pricing, including S. 727, Insulin for All Act of 2023; S. 1269, Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act of 2023; S. 146, Cap Insulin Prices Act; S 954, Affordable Insulin Now Act of 2023; HR 1488, Affordable Insulin Now Act; HR 1587, Making Insulin Affordable for All Children Act; HR 1485, Insulin for all Act of 2023. Issues related to mental health coverage, workforce, and mental health parity. Behavioral Health Network and Directory Improvement Act. S. 1001, Issues related to the Telehealth Expansion Act; H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023; H.R. 1843, the Telehealth Expansion Act of 2023. H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program. Issues relating to S. 464/ H.R. 2630, the Safe Step Act; related amendment to S. 1339, the Pharmacy Benefit Manager Reform Act. H.R. 5688, the Bipartisan HSA Improvement Act of 2023; H.R. 5687, the HSA Modernization Act of 2023. S. 2840, Bipartisan Primary Care and Health Workforce Act and issues related commercial insurance, telehealth, and pharmacy benefits.
Client expense: $1,630,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · third_quarter · Taxation/Internal Revenue Code
S. 464, No Tax Subsidies for E-Cigarette and Tobacco Ads Act S. 2929/H.R. 5715, Tobacco Tax Equity Act Issues surrounding Internal Revenue Code 420 Discussions concerning the tax rate on corporate stock buybacks and U.S. multinationals foreign earnings Discussions concerning draft legislation to amend corporate tax rates and federal excise taxes on tobacco products Discussions concerning a retaliatory tax on international companies from countries that adopt extraterritorial tax schemes Issues surrounding taxation of tobacco products
Client expense: $790,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · third_quarter · Tobacco
Issues related to lung disease treatment, prevention and research; Issues related to tobacco cessation; Issues related to smokefree air; Issues related to the Tobacco Control Act; Issues related to tobacco smuggling; Issues related to the Affordable Care Act; Issues related to menthol cigarettes; Issues related to tobacco prevention; Issues related to youth cessation research; Issues related to nicotine; Issues related to health equity; Issues related to COVID-19 Response; Issues related to tobacco litter; Issues related to synthetic nicotine; Issues related to regulatory reform; Issues relating to the Presidents FY24 budget; Issues relating to FY24 appropriations; HR 277 REINS Act; S 184 REINS Act; S. 107 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2023; HR 901 To require the Food and Drug Administration to prioritize enforcement of disposable electronic nicotine delivery system products; S. 464 No Tax Subsidies for E-Cigarette and Tobacco Ads; HR 2811 Limit Save Grow Act; HR 442 Regulatory Accountability Act; S 1615 Regulatory Accountability Act;; HR 288 Separation of Powers Restoration Act of 2023; HR 4368 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024; S.2131 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024; HR 4020 Children Don't Belong on Tobacco Farms Act; Issues related to Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2024; S 1411, Prove It Act of 2023; HR 4286 Increasing Access to Lung Cancer Screening Act; S 2213 Comprehensive Cancer Survivorship Act; HR 4363 Comprehensive Cancer Survivorship Act; HR 2398 To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes.; S 1040 To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes; S 2624 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024; HR 5525 Continuing Appropriations and Border Security Enhancement Act, 2024; HR 2860 Continuing Appropriations Act, 2024 and Other Extensions Act; HR 4286 Increasing Access to Lung Cancer Screening Act; HR 890 The Guidance Out of Darkness Act; S 791 The Guidance Out of Darkness Act; HR 4775 Helping Tobacco Users Quit Act
Client expense: $60,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, White House Office
2023 · third_quarter · Taxation/Internal Revenue Code
Issues related to taxes on tobacco products; Issues related to the Affordable Care Act; Issues related to COVID-19; Issues related to infrastructure; Issues relating to the Presidents FY24 budget; S. 464 No Tax Subsidies for E-Cigarette and Tobacco Ads;
Client expense: $60,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2023 · third_quarter · Health Issues
Palliative Care and Hospice Education and Training Act (PCHETA) (S.2243), Cancer Drug Parity Act (S.2039), Improving Care and Access to Nurses (H.R.2713/S. 2418), No Tax Subsidies for E-Cigarette and Tobacco Ads Act (S. 464/H.R. 4368), Safe Step Act (S. 652/H.R. 2630), National Triple-Negative Breast Cancer Day Resolution (H.R. 172), National Colorectal Cancer Awareness Month Resolution (H.R.213),Barbosa Act (S.302), Reducing Hereditary Cancer Act (S.765/H.R. 1526), National Cancer Prevention Day Resolution (H.R. 93), Colorectal Cancer Disparities Resolution (H.Res.224) Waiting for reintroduction: Improving Senior's Timely Access to Care Act,
Client expense: $47,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, White House Office
2023 · second_quarter · Health Issues
Issues related to surprise billing law and regulation. Issues related to P.L. 117-328, the Consolidated Appropriations Act 2023, including telehealth and redeterminations. Issues related to P.L. 117-169, the Inflation Reduction Act of 2022, including enhanced advance premium tax credits (APTCs) and Medicare Part D redesign. Issues related to removing barriers to biosimilar medicine access. Issues related to Quality-Adjusted Life Year (QALY) or similar metrics in health coverage legislation. Issues related to the proposed rule on Advancing Interoperability and Improving Prior Authorization Processes for Medicare Advantage Organizations, Medicaid Managed Care Plans, State Medicaid Agencies, Childrens Health Insurance Program (CHIP) Agencies and CHIP Managed Care Entities, Issuers of Qualified Health Plans on the Federally-facilitated Exchanges, Merit-based Incentive Payment System (MIPS) Eligible Clinicians, and Eligible Hospitals and Critical Access Hospitals in the Medicare Promoting Interoperability Program. Issues related to S. 113, the Prescription Pricing for the People Act; S. 127, the Pharmacy Benefit Manager Transparency Act; S. 1339, Pharmacy Benefit Manager Reform Act; S. 1542, the Delinking Revenue from Unfair Gouging Act (DRUG) Act; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2666, the Medicaid VBPs for Patients (MVP) Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023 (previously H.R. 2691Transparent PRICE Act); H.R. 3281, To promote hospital and insurer price transparency; H.R.2880, Protecting Patients Against PBM Abuses Act; H.R. 2679, the PBM Accountability Act; H.R.3285, the Fairness for Patient Medications Act, to establish patient protections with respect to highly rebated drugs; H.R. 3262, To amend title XI of the Social Security Act to increase transparency of certain health-related ownership information; H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 2666, the Medicaid VBPs for Patients (MVP) Act; H.R. 3284, the Providers and Payers COMPETE Act. H.R. 2813, Self-Insurance Protection Act. Issues related to insulin pricing, including S. 727, Insulin for All Act of 2023; S. 1269, Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act of 2023; S. 146, Cap Insulin Prices Act; S. 954, Affordable Insulin Now Act of 2023; H.R. 1488, Affordable Insulin Now Act; H.R. 1587, Making Insulin Affordable for All Children Act; H.R. 1485, Insulin for all Act of 2023. Issues related to mental health coverage, workforce, and mental health parity. Behavioral Health Network and Directory Improvement Act. S. 1001, Issues related to the Telehealth Expansion Act; H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023; H.R. 1843, the Telehealth Expansion Act of 2023. H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program. Issues relating to H.R. 3799, Custom Health Option and Individual Care Expense Arrangement Act (the CHOICE Arrangement Act). Issues relating to S. 464 / H.R. 2630, the Safe Step Act; related amendment to S. 1339.
Client expense: $1,650,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · second_quarter · Advertising
Issues relating to the deductibility of advertising as an ordinary business expense. Issues relating to advertising by cannabis businesses on broadcast stations in states where cannabis is legal. Issues relating to direct to consumer advertising. Issues relating to the regulation of political advertising. Issues relating to jurisdiction and treatment of broadcast advertising. H.R. 1118, Democracy Is Strengthened by Casting Light On Spending in Elections Act of 2023,Provisions relating to advertising on broadcast stations. H.R. 2422, Commercial Advertisement Loudness Mitigation Modernization Act of 2023, All provisions. H.R. 2599, Honest Ads Act, Provisions relating to advertising on broadcast stations. H.R. 3044, Require the Exposure of AI-Led Political Advertisements Act, Provisions relating to advertising on broadcast stations. S. 464, No Tax Subsidies for E-Cigarette and Tobacco Ads Act, All provisions. S. 486, Honest Ads Act, Provisions relating to advertising on broadcast stations. S. 512, Democracy Is Strengthened by Casting Light On Spending in Elections Act of 2023, Provisions relating to advertising on broadcast stations. S. 1073, Advertising Middlemen Endangering Rigorous Internet Competition Accountability Act, Provisions relating to digital advertising. S. 1127, A bill to amend the Commercial Advertisement Loudness Mitigation Modernization Act of 2023 to include video streaming services, and for other purposes.All provisions. S. 1596, Require the Exposure of AI-Led Political Advertisements Act, Provisions relating to advertising on broadcast stations.
Client expense: $2,730,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · second_quarter · Taxation/Internal Revenue Code
Issues related to taxes on tobacco products; Issues related to the Affordable Care Act; Issues related to COVID-19; Issues related to infrastructure; Issues relating to the Presidents FY24 budget; S. 464 No Tax Subsidies for E-Cigarette and Tobacco Ads; HR 3746 Fiscal Responsibility Act
Client expense: $70,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2023 · second_quarter · Tobacco
Issues related to lung disease treatment, prevention and research; Issues related to tobacco cessation; Issues related to smokefree air; Issues related to the Tobacco Control Act; Issues related to tobacco smuggling; Issues related to the Affordable Care Act; Issues related to menthol cigarettes; Issues related to tobacco prevention; Issues related to youth cessation research; Issues related to nicotine; Issues related to health equity; Issues related to COVID-19 Response; Issues related to tobacco litter; Issues related to synthetic nicotine; Issues related to regulatory reform; Issues relating to the Presidents FY24 budget; Issues relating to FY24 appropriations; HR 277 REINS Act; S 184 REINS Act; S. 107 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2023; HR 901 To require the Food and Drug Administration to prioritize enforcement of disposable electronic nicotine delivery system products; S. 464 No Tax Subsidies for E-Cigarette and Tobacco Ads; HR 2811 Limit Save Grow Act; HR 442 Regulatory Accountability Act; S 1615 Regulatory Accountability Act; HR 3746 Fiscal Responsibility Act of 2023; HR 288 Separation of Powers Restoration Act of 2023; HR 4368 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024; S.2131 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024; HR 4020 Children Don't Belong on Tobacco Farms Act; Issues related to Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2024; S 1411, Prove It Act of 2023; HR 4286 Increasing Access to Lung Cancer Screening Act; S 2213 Comprehensive Cancer Survivorship Act; HR 4363 Comprehensive Cancer Survivorship Act; HR 2398 To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes.; S 1040 To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes.
Client expense: $70,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, White House Office
2023 · second_quarter · Taxation/Internal Revenue Code
S. 464, No Tax Subsidies for E-Cigarette and Tobacco Ads Act Discussions concerning the tax rate on corporate stock buybacks and U.S. multinationals foreign earnings Discussions concerning draft legislation to amend corporate tax rates and federal excise taxes on tobacco products Discussions concerning a retaliatory tax on international companies from countries that adopt extraterritorial tax schemes Issues surrounding taxation of tobacco products
Client expense: $900,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · second_quarter · Health Issues
Palliative Care and Hospice Education and Training Act (PCHETA) (S.2243), Cancer Drug Parity Act (S.2039), Improving Care and Access to Nurses ((H.R.2713), No Tax Subsidies for E-Cigarette and Tobacco Ads Act (S. 464), Safe Step Act (S. 652), National Triple-Negative Breast Cancer Day Resolution (H.R. 172), National Colorectal Cancer Awareness Month Resolution (H.R.213),Barbosa Act (S.302), Reducing Hereditary Cancer Act (S.765/H.R. 1526), National Cancer Prevention Day Resolution (H.R. 93), Colorectal Cancer Disparities Resolution (H.Res.224) Waiting for reintroduction: Improving Senior's Timely Access to Care Act,
Client expense: $81,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, White House Office